Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
PLoS One
2009 Dec 29;412:e8478. doi: 10.1371/journal.pone.0008478.
Show Gene links
Show Anatomy links
The function of cortactin in the clustering of acetylcholine receptors at the vertebrate neuromuscular junction.
Madhavan R
,
Gong ZL
,
Ma JJ
,
Chan AW
,
Peng HB
.
???displayArticle.abstract???
BACKGROUND: Postsynaptic enrichment of acetylcholine receptors (AChRs) at the vertebrate neuromuscular junction (NMJ) depends on the activation of the muscle receptor tyrosine MuSK by neural agrin. Agrin-stimulation of MuSK is known to initiate an intracellular signaling cascade that leads to the clustering of AChRs in an actin polymerization-dependent manner, but the molecular steps which link MuSK activation to AChR aggregation remain incompletely defined.
METHODOLOGY/PRINCIPAL FINDINGS: In this study we used biochemical, cell biological and molecular assays to investigate a possible role in AChR clustering of cortactin, a protein which is a tyrosine kinase substrate and a regulator of F-actin assembly and which has also been previously localized at AChR clustering sites. We report that cortactin was co-enriched at AChR clusters in situ with its target the Arp2/3 complex, which is a key stimulator of actin polymerization in cells. Cortactin was further preferentially tyrosine phosphorylated at AChR clustering sites and treatment of myotubes with agrin significantly enhanced the tyrosine phosphorylation of cortactin. Importantly, forced expression in myotubes of a tyrosine phosphorylation-defective cortactin mutant (but not wild-type cortactin) suppressed agrin-dependent AChR clustering, as did the reduction of endogenous cortactin levels using RNA interference, and introduction of the mutant cortactin into muscle cells potently inhibited synaptic AChR aggregation in response to innervation.
CONCLUSION: Our results suggest a novel function of phosphorylation-dependent cortactin signaling downstream from agrin/MuSK in facilitating AChR clustering at the developing NMJ.
???displayArticle.pubmedLink???
20041195
???displayArticle.pmcLink???PMC2793544 ???displayArticle.link???PLoS One
Figure 1. Localization of Arp2/3 complex proteins and cortactin at AChR clustering sites.Cultured embryonic Xenopus muscle cells labeled with rhodamine-α-bungarotoxin (R-BTX) were stimulated overnight with polystyrene beads coated with heparan-binding growth-associated molecule (HB-GAM) (A, D; asterisks) to induce AChR clusters (C, F). Cells were then fixed and labeled with affinity-purified polyclonal antibodies against the Arp2/3 complex proteins Arp2 (B) and p34arc (E) followed by FITC-linked anti-rabbit secondary antibodies. Separately, bead-stimulated muscle cells (G) were labeled with anti-p34arc polyclonal (H) and anti-cortactin monoclonal (I; mAb4F11) antibodies and then FITC-conjugated anti-rabbit and rhodamine-conjugated anti-mouse secondary antibodies. AChRs, Arp2 and p34arc were clustered at bead-muscle contacts (A-F; arrows) where cortactin localized and overlapped in distribution with p34arc (H and I; arrows). In primary muscle cultures non-muscle cells were occasionally found (J) and in these cells p34arc (K) and cortactin (L) localized along the cell periphery (arrowheads) but were not clustered at bead-cell contacts (“b” in K and L corresponds to bead indicated by asterisk in J).
Figure 2. Tyrosine phosphorylation of cortactin at pre-patterned and nerve-induced AChR clusters.Xenopus muscle cells were labeled with R-BTX and after fixation with an antibody that specifically recognizes Y482-phospho-cortactin (plus FITC-linked anti-rabbit antibodies) (A-F). In some cases muscle cells were first co-cultured for 1 d with spinal neurons and then labeled with R-BTX and anti-phospho-cortactin and secondary antibodies (G-I). In pure muscle cultures (A, D) large “pre-patterned” AChR clusters were present (B, E; arrows) and at these sites staining by anti-phospho-cortactin was significantly stronger than elsewhere in muscle cells (C, F; arrows). Labeling for phospho-cortactin was detected at almost all pre-patterned clusters examined (see Table S1), although within the clusters certain regions at times appeared to be more enriched in phospho-cortactin than others (as in F; arrow versus arrowhead). The anti-phospho-cortactin antibody also labeled muscle cell edges (C, F) where cortactin is known to be localized. In nerve-muscle co-cultures (G) AChRs were selectively concentrated at synaptic contacts (H; arrows) and these nerve-induced AChR clusters were also labeled by the anti-phospho-cortactin antibody (I; arrows).
Figure 3. Cortactin phosphorylation at AChR clusters induced by growth factor-coated beads and agrin.R-BTX-labeled Xenopus muscle cells were stimulated overnight with HB-GAM-beads (A-C) or neural agrin (D-F). In cells exposed to beads (A; asterisks) AChRs aggregated at bead-muscle contacts (B; arrows) and strong labeling was detected at these bead-induced AChR clusters for Y482-phospho-cortactin (C; arrows). Treatment of muscle cells with agrin (D) generated numerous small (∼0.5-3 µm) AChR clusters (D; arrows) and antibody labeling showed that phospho-cortactin was enriched at these clusters (E; arrows) and also along myopodia that formed near the AChR clusters (F; arrows and arrowheads).
Figure 4. Agrin-dependent enhancement of cortactin tyrosine phosphorylation.Cultured C2 mouse myotubes were exposed to medium without (-) or with added agrin (+) before preparing extracts for immuno-precipitation (A) with a monoclonal antibody against cortactin (IP: cort) or an unrelated protein (IP: ctl). When these samples were immuno-blotted for cortactin (IB: cort) and total phosphotyrosine (IB: PY; mAb4G10), cortactin was found to be captured only by the anti-cortactin antibody (upper lanes), and anti-phosphotyrosine staining showed that cortactin from extracts of agrin-treated cells was tyrosine phosphorylated significantly more than that captured from control extracts (lower lanes). This increase in cortactin phosphorylation was quantified from four experiments (A, graph) by measuring band densities, normalizing for cortactin loading (see Methods), and calculating the phosphotyrosine level change relative to control. B. To test whether the src-target sites in cortactin were phosphorylated in response to agrin-treatment, myotube extracts were blotted with antibodies against total cortactin and cortactin phosphorylated on Y421. Agrin-treatment did not alter the amount of cortactin present in extracts (upper lanes) but the staining of cortactin by the anti-Y421-phospho-cortactin antibody (IB: pCort) was enhanced by agrin-treatment more than two-fold, as shown by quantification from three experiments (B, graph). Positions of pre-stained MW markers (Bio-Rad) are indicated on the right side of blots, and in the graphs * represents P<0.02 in t-tests.
Figure 5. Inhibition of agrin-induced AChR clustering by forced expression of phospho-mutant cortactin in myotubes.To examine the effect of exogenous cortactin proteins on AChR clustering, C2 myotubes were transfected with mRNAs encoding GFP (Ctl) or GFP-tagged phospho-mutant (3YF) cortactin or wild-type (WT) cortactin. After treating myotubes with agrin overnight, cells expressing exogenous proteins (A, D, G; asterisks) were identified by green fluorescence (B, E, H) and the AChR clusters present on the surface of these cells were examined by R-BTX-labeling (C, F, I; arrows). Forced expression of the phospho-mutant, but not wild-type, cortactin reduced the number and lengths of agrin-induced AChR clusters in myotubes. J. To biochemically confirm the expression of exogenous cortactin proteins in myotubes, extracts prepared from myotubes transfected with mRNAs encoding GFP, GFP-tagged WT and 3YF cortactin were immuno-blotted with anti-cortactin monoclonal antibody mAb4F11. Myotubes transfected with GFP mRNA (G) contained full-length endogenous cortactin (arrow on left), but those transfected with WT- and 3YF-cortactin mRNAs contained endogenous cortactin plus a protein (∼25 kD larger) corresponding to exogenous, GFP-tagged cortactin (asterisk). MW marker positions are indicated on the right. K-L. Myotubes transfected with GFP or GFP-tagged cortactin proteins were selected randomly and the numbers and lengths of the AChR clusters present on their surface were determined; data from five separate transfection experiments were pooled and normalized relative to values obtained from GFP-tranfected cells. Fewer (K) and smaller (L) AChR clusters were present in myotubes expressing phospho-mutant cortactin than in cells expressing GFP alone or WT-cortactin-GFP. Mean and SEM values are shown, *P<0.05.
Figure 6. Inhibition of agrin-induced AChR clustering by down-regulation of cortactin expression in myotubes.C2 myotubes generated from myoblasts transfected with control siRNAs (A-C) or a pool of siRNAs directed against mouse cortactin (D-F) (both mixed with a cDNA encoding GFP) were incubated overnight in differentiation medium containing agrin before labeling with R-BTX. Transfected myotubes (A, D; asterisks) were identified by green fluorescence (B, E), and the AChR clusters present on their surface (C, F; arrows) were counted and the lengths of these clusters were measured. G. To demonstrate that siRNAs against cortactin knocked down cortactin expression, in each experiment extracts were prepared from myotubes generated from myoblasts transfected in parallel and maintained under conditions identical to those used for examining agrin-induced AChR clustering. Extracts of cells transfected with GFP cDNA plus control (p120ctn) siRNA (Ctl; left lane), cortactin siRNA (middle lane) or GFP cDNA alone (right lane) were immuno-blotted with antibodies against cortactin (upper blot) or tubulin (lower blot). The cortactin siRNA suppressed the expression of cortactin without affecting unrelated proteins (such as tubulin, which is also shown here to demonstrate equal protein loading), and cortactin's expression was not affected by control siRNAs or by transfection procedures (where only GFP cDNA was used). From four transfection experiments AChR cluster data from control (Ctl) and mouse cortactin (msCort) siRNA-transfected myotubes were pooled and normalized relative to those obtained from cells transfected with the control siRNA. These results showed that agrin-induced AChR cluster numbers (H) and lengths (I) were significantly lower in myotubes expressing reduced levels of endogenous cortactin compared to those expressing normal levels of cortactin. Mean and SEM values are shown, *P<0.05.
Figure 7. Suppression of synaptic AChR aggregation by phospho-mutant cortactin expressed selectively in muscle cells.Xenopus embryonic muscle cells expressing GFP (A-D) and GFP-tagged wild-type cortactin (WT-cort; E-H) and phospho-mutant cortactin (3YF-cort; I-N) were co-cultured with spinals neurons for 1 d and then labeled with R-BTX to visualize AChR clusters. Cells expressing the exogenous proteins fluoresced green and AChR clusters appeared red, as shown in this figure with 2-3 representative examples of nerves contacting muscle cells with GFP or GFP-tagged cortactin proteins. In the GFP and WT-cort muscle cells (A-H), AChRs were tightly clustered (arrows) along nerve-contacts identified (traced in white in colored panels) but this was not the case in 3YF-cort cells where nerves often induced no AChR clustering (J) or induced few clusters that were loosely organized (L; arrowheads). We found cases where the same neurites moved across normal muscle cells and 3YF-cells (M-N) and in such cases synaptic AChR clustering was robust in the normal cells (arrows) but not mutant cells (arrowheads). O. The percentages of nerve-contacts with AChR clusters were determined by examining several co-cultures with muscle cells expressing GFP or the GFP-tagged cortactin proteins (see Methods) and these values were normalized relative to numbers obtained from examining nerve-contacts on GFP-cells. In muscle cells expressing phospho-mutant cortactin, synaptic AChR clustering was almost halved. Nerve-muscle contacts examined: GFP cells, 168; WT-cort cells, 214; 3YF-cort cells, 225; mean and SEM shown, *P<0.0001.
Figure 8. Cortactin signaling in agrin-dependent AChR clustering: a model.Activation of MuSK by agrin induces AChR clustering in an actin polymerization-dependent manner. This model depicts a possible way in which cortactin signaling might promote the AChR clustering process. Initiation of intracellular signaling by the activated MuSK complex could enhance cortactin's tyrosine phosphorylation through src family tyrosine kinases (SFKs) (and possibly other kinases such as abl), and cortactin, in turn, could increase actin polymerization. Alternatively, cortactin might trigger actin polymerization by activating the Arp2/3 complex, either on its own or in concert with WASP-related proteins (N-WASP, WIP, etc.) to which it could be linked by the adapter Nck. In parallel, via other signaling intermediates, MuSK could stimulate Rho-family GTPases and, through them, F-actin assembly. Such enhanced and dynamic actin polymerization at synaptic sites could generate a scaffold which “traps” AChRs through rapsyn.
Abu-Elneel,
A delta-catenin signaling pathway leading to dendritic protrusions.
2008, Pubmed
Abu-Elneel,
A delta-catenin signaling pathway leading to dendritic protrusions.
2008,
Pubmed
Ammer,
Cortactin branches out: roles in regulating protrusive actin dynamics.
2008,
Pubmed
Boguslavsky,
p120 catenin regulates lamellipodial dynamics and cell adhesion in cooperation with cortactin.
2007,
Pubmed
Borges,
Identification of a motif in the acetylcholine receptor beta subunit whose phosphorylation regulates rapsyn association and postsynaptic receptor localization.
2008,
Pubmed
Borges,
Agrin-induced phosphorylation of the acetylcholine receptor regulates cytoskeletal anchoring and clustering.
2001,
Pubmed
Bruneau,
Receptor-associated proteins and synaptic plasticity.
2009,
Pubmed
Camilleri,
Tyrosine phosphatases such as SHP-2 act in a balance with Src-family kinases in stabilization of postsynaptic clusters of acetylcholine receptors.
2007,
Pubmed
Cosen-Binker,
Cortactin: the gray eminence of the cytoskeleton.
2006,
Pubmed
Daggett,
Full-length agrin isoform activities and binding site distributions on cultured Xenopus muscle cells.
1996,
Pubmed
,
Xenbase
Dai,
The actin-driven movement and formation of acetylcholine receptor clusters.
2000,
Pubmed
,
Xenbase
Edwards,
A model for the localization of acetylcholine receptors at the muscle endplate.
1976,
Pubmed
Fertuck,
Quantitation of junctional and extrajunctional acetylcholine receptors by electron microscope autoradiography after 125I-alpha-bungarotoxin binding at mouse neuromuscular junctions.
1976,
Pubmed
Friese,
Synaptic differentiation is defective in mice lacking acetylcholine receptor beta-subunit tyrosine phosphorylation.
2007,
Pubmed
Gautam,
Failure of postsynaptic specialization to develop at neuromuscular junctions of rapsyn-deficient mice.
1995,
Pubmed
Geng,
Transmembrane mechanisms in the assembly of the postsynaptic apparatus at the neuromuscular junction.
2008,
Pubmed
Geng,
The formation of acetylcholine receptor clusters visualized with quantum dots.
2009,
Pubmed
,
Xenbase
Glass,
Agrin acts via a MuSK receptor complex.
1996,
Pubmed
Goley,
The ARP2/3 complex: an actin nucleator comes of age.
2006,
Pubmed
Hall,
Rho GTPases and the control of cell behaviour.
2005,
Pubmed
Hering,
Activity-dependent redistribution and essential role of cortactin in dendritic spine morphogenesis.
2003,
Pubmed
Huang,
The role of tyrosine phosphorylation of cortactin in the locomotion of endothelial cells.
1998,
Pubmed
Jaworski,
Dynamic microtubules regulate dendritic spine morphology and synaptic plasticity.
2009,
Pubmed
Kim,
Lrp4 is a receptor for Agrin and forms a complex with MuSK.
2008,
Pubmed
Kummer,
Assembly of the postsynaptic membrane at the neuromuscular junction: paradigm lost.
2006,
Pubmed
Le Clainche,
Regulation of actin assembly associated with protrusion and adhesion in cell migration.
2008,
Pubmed
Lin,
Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse.
2001,
Pubmed
Linnoila,
A mammalian homolog of Drosophila tumorous imaginal discs, Tid1, mediates agrin signaling at the neuromuscular junction.
2008,
Pubmed
Luo,
Regulation of AChR clustering by Dishevelled interacting with MuSK and PAK1.
2002,
Pubmed
,
Xenbase
Luo,
Implication of geranylgeranyltransferase I in synapse formation.
2003,
Pubmed
,
Xenbase
Luo,
Signaling complexes for postsynaptic differentiation.
2003,
Pubmed
Madhavan,
Involvement of p120 catenin in myopodial assembly and nerve-muscle synapse formation.
2006,
Pubmed
,
Xenbase
Madhavan,
Tyrosine phosphatase regulation of MuSK-dependent acetylcholine receptor clustering.
2005,
Pubmed
,
Xenbase
Madhavan,
A synaptic balancing act: local and global signaling in the clustering of ACh receptors at vertebrate neuromuscular junctions.
2003,
Pubmed
Madhavan,
Molecular regulation of postsynaptic differentiation at the neuromuscular junction.
2005,
Pubmed
McMahan,
The agrin hypothesis.
1990,
Pubmed
Misgeld,
Agrin promotes synaptic differentiation by counteracting an inhibitory effect of neurotransmitter.
2005,
Pubmed
Moransard,
Agrin regulates rapsyn interaction with surface acetylcholine receptors, and this underlies cytoskeletal anchoring and clustering.
2003,
Pubmed
Nizhynska,
Phosphoinositide 3-kinase acts through RAC and Cdc42 during agrin-induced acetylcholine receptor clustering.
2007,
Pubmed
Okada,
The muscle protein Dok-7 is essential for neuromuscular synaptogenesis.
2006,
Pubmed
Peng,
Association of cortactin with developing neuromuscular specializations.
1997,
Pubmed
,
Xenbase
Peng,
Tissue culture of Xenopus neurons and muscle cells as a model for studying synaptic induction.
1991,
Pubmed
,
Xenbase
Qian,
The function of Shp2 tyrosine phosphatase in the dispersal of acetylcholine receptor clusters.
2008,
Pubmed
,
Xenbase
Sanes,
Induction, assembly, maturation and maintenance of a postsynaptic apparatus.
2001,
Pubmed
Smith,
Src, Fyn, and Yes are not required for neuromuscular synapse formation but are necessary for stabilization of agrin-induced clusters of acetylcholine receptors.
2001,
Pubmed
Tehrani,
Src phosphorylation of cortactin enhances actin assembly.
2007,
Pubmed
Weatherbee,
LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction.
2006,
Pubmed
Weaver,
Interaction of cortactin and N-WASp with Arp2/3 complex.
2002,
Pubmed
Weaver,
Integration of signals to the Arp2/3 complex.
2003,
Pubmed
Weston,
Cooperative regulation by Rac and Rho of agrin-induced acetylcholine receptor clustering in muscle cells.
2003,
Pubmed
Wiesner,
Regulation of nicotinic acetylcholine receptors by tyrosine kinases in the peripheral and central nervous system: same players, different roles.
2006,
Pubmed
Wu,
Identification and characterization of a novel cytoskeleton-associated pp60src substrate.
1991,
Pubmed
Wu,
Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex.
1993,
Pubmed
Yang,
Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation.
2001,
Pubmed
Zhang,
LRP4 serves as a coreceptor of agrin.
2008,
Pubmed
Zhao,
Regulation of ACh receptor clustering by the tyrosine phosphatase Shp2.
2007,
Pubmed